April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)
Research has investigated the peptides influence on gene expression, tissue regeneration pathways, and inflammatory modulation in a variety of experimental models
Copper peptides are small chains of amino acids bonded to copper ions
This reduction may influence extracellular matrix remodeling, immune cell recruitment, and paracrine signaling in surrounding tissues
Anemia of inflammatory disease may be compounded by other conditions, such as blood loss and nutritional deficiencies
GHKCu may increase expression of certain hormone receptors or enhance downstream signaling, improving tissue responses to circulating hormones